Scilex Holding (SCLXW) Tax Provisions (2022 - 2025)
Scilex Holding (SCLXW) recorded quarterly Tax Provisions of $6000.0 in Q4 2025, up 500.0% quarter-over-quarter from $1000.0 in Q3 2025, and up 700.0% on a YoY basis from $750.0 in Q4 2024.
Scilex Holding (SCLXW) Tax Provisions (2022 - 2025) Analysis & Trends
Scilex Holding's Tax Provisions history runs 4 years deep, the most recent figure standing at $6000.0 for Q4 2025.
- In Q4 2025, Tax Provisions rose 700.0% year-over-year to $6000.0; the TTM figure through Dec 2025 stood at $25000.0 (up 2600.0% YoY), while the FY2025 annual figure was $26000.0, up 2700.0% from the prior year.
- Tax Provisions was $6000.0 for Q4 2025 at Scilex Holding, up from $1000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $40000.0 in Q4 2022 to a low of -$28000.0 in Q2 2022.
- Historically, Tax Provisions has averaged $3818.2 across 4 years, with a median of $3000.0 in 2022.
- The sharpest annual moves came in 2024 and 2025: Tax Provisions plunged 112.5% in 2024, then jumped 700.0% in 2025.
- A 4-year view of Tax Provisions shows it stood at $40000.0 in 2022, then plunged by 80.0% to $8000.0 in 2023, then slumped by 112.5% to -$1000.0 in 2024, then surged by 700.0% to $6000.0 in 2025.
- The last three Tax Provisions figures came in at $6000.0 (Q4 2025), $1000.0 (Q3 2025), and $19000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | -411.19 Mn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 1.45 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 755.00 Mn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 342.00 Mn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 709.00 Mn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 265.00 Mn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 559.00 Mn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 461.00 Mn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 561.00 Mn |
| 10 | Scilex Holding | - | - | 4.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2023 | 8,000.00 |
| Jun 30, 2023 | -3,000.00 |
| Mar 31, 2023 | 8,000.00 |
| Dec 31, 2022 | 40,000.00 |
| Sep 30, 2022 | -11,000.00 |
| Jun 30, 2022 | -28,000.00 |
| Mar 31, 2022 | 3,000.00 |